Crouse Health Online: Wellness is just a click away.
Share Share
  |  Connect with Us: 
Text Size

Health News

New Guidelines Issued for Genetic Heart Disease

New Guidelines Issued for Genetic Heart Disease


TUESDAY, Nov. 8 (HealthDay News) -- Most people with a genetic heart disease called hypertrophic cardiomyopathy (HCM) can live a normal length of time, according to the first science-based guideline for diagnosing and treating the condition.

About 600,000 Americans have HCM, which affects about one in 500 people worldwide. HCM, the most common type of genetic cardiac disease, alters the way the heart functions and can cause erratic heart beats, obstructed blood flow, and sudden cardiac death.

However, many people with HCM experience no problems, according to the guideline from the American College of Cardiology Foundation and the American Heart Association (ACCF/AHA).

"HCM is widely misperceived as a fatal condition, but a diagnosis of HCM is not a diagnosis of sudden cardiac death. We now have effective treatments to help most patients manage the condition, although it remains the most common cause of sudden death in the young and in competitive athletes," guideline writing committee co-chairmain Dr. Bernard J. Gersh, a professor of medicine at the Mayo Clinic College of Medicine in Rochester, Minn., said in an ACCF/AHA news release.

Standard drug therapy includes beta- and calcium-channel blockers. For patients who don't respond to these drugs, there are effective surgical and catheter-based approaches, according to the guideline.

All patients diagnosed with HCM should undergo a thorough evaluation of their risk for sudden cardiac arrest, including a personal and family history and an echocardiogram.

If appropriate, HCM patients should be offered genetic counseling and genetic testing.

Patients with HCM should not participate in intense competition sports but can play low-intensity sports such as golf and take part in a number of recreational sporting activities, according to the guideline.

An implantable defibrillator can reduce the risk of sudden death in certain HCM patients judged to be at high risk based on markers such as fainting or having a family member who suffered sudden death.

The guideline is published in the current online edition of the Journal of the American College of Cardiology and in Circulation.

More information

The U.S. National Library of Medicine has more about hypertrophic cardiomyopathy.

Copyright © 2011 HealthDay. All rights reserved.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.


Latest News

Crouse Hospital Appoints Chief Information Officer
more >

MedEx Bedside Prescription Delivery Service

Free service offers convenience, patient education at discharge.
more >

Weight Loss Surgery

Is it right for you? Attend a free information seminar held twice monthly.
more >

Quality at Crouse

See how Crouse Hospital strives to provide the best in patient care.
more >

Cheer Up That Special Someone

Say get well or welcome a new arrival with a gift purchased right at Crouse.

more >

Make an Online Donation Now

Your donation of any amount helps support Crouse services & programs in a meaningful way.
more >

Shop Online Now

Say get well, thinking of you or welcome new baby with a unique gift from the Crouse Gift Shop.

more >